Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 383,221 | 395,026 | 127,372 | 118,218 | 128,030 |
| Marketable Securities | 98,956 | 123,423 | 167,461 | 111,959 | 128,519 |
| Receivables | 43,768 | 34,029 | 41,907 | 36,292 | 37,818 |
| TOTAL | $536,409 | $568,364 | $355,502 | $284,476 | $315,092 |
| Non-Current Assets | |||||
| PPE Net | 744 | 821 | 903 | 952 | 1,039 |
| Other Non-Current Assets | 39,645 | 40,530 | 42,440 | 42,743 | 44,115 |
| TOTAL | $40,389 | $41,351 | $43,343 | $43,695 | $45,154 |
| Total Assets | $576,798 | $609,715 | $398,845 | $328,171 | $360,246 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,143 | 7,443 | 5,320 | 7,499 | 11,815 |
| Accrued Expenses | 50,855 | 18,963 | 21,435 | 19,936 | 27,570 |
| TOTAL | $57,998 | $26,406 | $26,755 | $27,435 | $39,385 |
| Non-Current Liabilities | |||||
| Long Term Debt | 108,940 | 75,700 | 76,500 | 76,800 | 75,700 |
| Other Non-Current Liabilities | 8,315 | 8,472 | 8,625 | 8,773 | 8,917 |
| TOTAL | $117,255 | $84,172 | $85,125 | $85,573 | $84,617 |
| Total Liabilities | $175,253 | $110,578 | $111,880 | $113,008 | $124,002 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133,184 | 131,846 | 113,314 | 113,044 | 100,306 |
| Common Shares | 359 | 357 | 309 | 277 | 273 |
| Retained earnings | -988,702 | -877,373 | -834,807 | -790,991 | -752,945 |
| Other shareholders' equity | 4,213 | 2,095 | 1,595 | 1,623 | 1,493 |
| TOTAL | $401,545 | $499,137 | $286,965 | $215,163 | $236,244 |
| Total Liabilities And Equity | $576,798 | $609,715 | $398,845 | $328,171 | $360,246 |